Mustgrow Financial Statements From 2010 to 2026
| MGROF Stock | USD 0.46 0.01 2.22% |
Check Mustgrow Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mustgrow Biologics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Mustgrow financial statements analysis is a perfect complement when working with Mustgrow Biologics Valuation or Volatility modules.
Mustgrow |
Mustgrow Biologics Corp OTC Stock Return On Asset Analysis
Mustgrow Biologics' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Mustgrow Biologics Return On Asset | -0.59 |
Most of Mustgrow Biologics' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mustgrow Biologics Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Mustgrow Biologics Corp has a Return On Asset of -0.5869. This is 179.31% lower than that of the Basic Materials sector and 158.69% lower than that of the Agricultural Inputs industry. The return on asset for all United States stocks is notably higher than that of the company.
Mustgrow Biologics Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mustgrow Biologics's current stock value. Our valuation model uses many indicators to compare Mustgrow Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mustgrow Biologics competition to find correlations between indicators driving Mustgrow Biologics's intrinsic value. More Info.Mustgrow Biologics Corp is considered to be number one stock in return on equity category among its peers. It is regarded third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mustgrow Biologics' earnings, one of the primary drivers of an investment's value.About Mustgrow Biologics Financial Statements
Mustgrow Biologics stakeholders use historical fundamental indicators, such as Mustgrow Biologics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Mustgrow Biologics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mustgrow Biologics' assets and liabilities are reflected in the revenues and expenses on Mustgrow Biologics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mustgrow Biologics Corp. Please read more on our technical analysis and fundamental analysis pages.
MustGrow Biologics Corp., an agricultural biotech company, focuses om development and commercialization of natural biopesticide, biofumigants, and bioherbicides derived from mustard seed. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada. MUSTGROW BIOLOGICS is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Mustgrow OTC Stock
Mustgrow Biologics financial ratios help investors to determine whether Mustgrow OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mustgrow with respect to the benefits of owning Mustgrow Biologics security.